Zhizhen Dong
Nantong, 226001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma.
Journal: Cancer management and research
Published: December 13, 2018
Secretory Clusterin as a Novel Molecular-targeted Therapy for Inhibiting Hepatocellular Carcinoma Growth.
Journal: Current medicinal chemistry
Published: October 13, 2018
Role of secretory clusterin in hepatocarcinogenesis.
Journal: Translational gastroenterology and hepatology
Published: May 18, 2018
Ang-2 promotes lung cancer metastasis by increasing epithelial-mesenchymal transition.
Journal: Oncotarget
Published: October 26, 2017
Advances in the study of oncofetal antigen glypican-3 expression in HBV-related hepatocellular carcinoma.
Journal: Bioscience trends
Published: November 01, 2016
Insulin-like Growth Factor I Receptor: A Novel Target for Hepatocellular Carcinoma Gene Therapy.
Journal: Mini reviews in medicinal chemistry
Published: May 24, 2016
Expression of oncofetal antigen glypican-3 associates significantly with poor prognosis in HBV-related hepatocellular carcinoma.
Journal: Oncotarget
Published: April 18, 2016
Abnormal expression of circulating nuclear factor-κB in hepatocellular carcinoma and reversal of multidrug resistance through intervening its gene transcription
Journal: Zhonghua yi xue za zhi
Published: April 09, 2016
Inhibitory effects of intervention of the TNFa/NF-kappaB signaling pathway activation on hepatoma cell proliferation
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: September 10, 2014
Down-regulating glypican-3 expression: molecular-targeted therapy for hepatocellular carcinoma.
Journal: Mini reviews in medicinal chemistry
Published: June 15, 2014
Last Updated: 09/26/2026